Table 1 Characteristics of patients and transplantations with late de novo DSA
Patients with late dnDSA (n = 22) | |
|---|---|
Recipients’ characteristics | |
Age in years; mean (SD) | 45 (14) |
Gender (% male) | 63.6 |
First transplantation (%) | 100 |
Living donor (% yes) | 36.3 |
Baseline nephropathy (%) | |
○ ADPKD | 31.5 |
○ Glomerulopathy other than IgA nephropathy | 18.3 |
○ IgA nephropathy | 18.3 |
○ Diabetes mellitus and/or hypertension | 13.6 |
○ Others | 18.3 |
Transplantation characteristics | |
HLA mismatches (% patients with > or = 3 mismatches) | 100 |
ABO incompatible (n) | 1 |
Delayed graft function (n, %) | 8 (36.3) |
Induction therapy (n, %) | |
○ No induction | 8 (36.3) |
○ Basiliximab | 8 (36.3) |
○ ATG | 5 (22.7) |
○ Daclizumab | 1 (4.5) |
Initial therapy including a triple regimena (n, %) | 21 (95.4) |
Acute rejection or TCMR prior to development of dnDSA (n, %) | 8 (36.3) |